Rafael Holdings, Inc. (RFL): Operating Cash Flow
-$29.99M
Year ended 2026-07-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | -$29.99M | n/m | 2026-10-29, From 2025-08-01 |
| 2025-07-31 | -$18.92M | n/m | 2026-10-29, From 2024-08-01 |
| 2024-07-31 | -$7.80M | n/m | 2025-10-29, From 2023-08-01 |
| 2023-07-31 | -$10.89M | n/m | 2024-12-20, From 2022-08-01 |
| 2022-07-31 | -$26.08M | n/m | 2023-10-30, From 2021-08-01 |
| 2021-07-31 | -$15.60M | n/m | 2022-10-31, From 2020-08-01 |
| 2020-07-31 | -$4.67M | n/m | 2021-10-18, From 2019-08-01 |
| 2019-07-31 | -$3.13M | n/m | 2020-10-29, From 2018-08-01 |
| 2018-07-31 | -$1.81M | n/m | 2019-10-04, From 2017-08-01 |
| 2017-07-31 | -$1.62M | n/m | 2018-10-15, From 2016-08-01 |
| 2016-07-31 | $72.0K | n/a | 2018-10-15, From 2015-08-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2026-07-31 | -$29.99M | n/m |
| Rallybio Corp (RLYB) | 2025-12-31 | -$29.81M | n/m |
| Onconetix, Inc. (ONCO) | 2025-12-31 | -$9.68M | n/m |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | -$39.88M | n/m |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | -$6.85M | n/m |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | -$9.90M | n/m |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | -$10.45M | n/m |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | -$4.02M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$12.35M | n/m |
Compare RFL, RLYB, ONCO, STTK side by side · Screen every company in Pharmaceutical Preparations ↗